Pharmafile Logo

Education, AI and More at ASH 2024

November 25, 2024 |  

Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and oncology education. The presentations will reflect on the impact of last year’s programs, including a virtual patient simulation and collaborations with the Leukemia & Lymphoma Society. Additionally, Medscape will introduce new AI capabilities to enhance learning experiences for healthcare professionals, reinforcing their commitment to improving patient care through innovative education.

- PMLiVE

As the conference year draws to a close, Medscape is closing out the season in a big way, bringing 8 educational symposia and 3 posters to ASH 2024, as well as showcasing new AI capabilities.

Three posters are being presented on December 5, before the official start of the conference. In the first poster, Medscape is taking a retrospective look examining the impact of the programs produced for ASH 2023. The outcomes of this study showed how the programs made a difference in learners’ knowledge, competency, and confidence, as assessed by pre-and post-education questions. Attendees who are interested in simulation can check out Medscape’s second poster, which looks at the impact of a Medscape virtual patient simulation on cold agglutinin disease. Medscape’s third poster, on BTK inhibitors for chronic lymphocytic leukemia and mantle cell lymphoma, was created through the collaboration with The Leukemia & Lymphoma Society, a renowned patient advocacy group.

“It’s always so inspiring to look back at some of our education efforts over the past year and see how much of an impact they made. We’re proud to have worked with the Leukemia & Lymphoma Society to analyze and present the impact of some of our education in chronic lymphocytic leukemia and mantle cell lymphoma and show how education is making a difference,” said Dr Victoria Harvey-Jones, Associate Director of Clinical Strategy, Medscape Oncology Global and leader of Medscape’s Patient-Integration Initiative.

The 8 educational symposia for 2024 will cover the following topics:

All symposia offer the ability to engage with the faculty as well as send notes and slides. Programs will be made available on Medscape.org following the conference.
New for 2024, Medscape will showcase AI features at their booth, allowing attendees to take a glimpse into the powerful ways Medscape is harnessing this technology to enhance education. Conference attendees are encouraged to stop by the Medscape booth during exhibitor hours to try it for themselves.

“Our AI pilot at ASH 2024 is game-changing. We’ve partnered with Erudio Health to pilot new tools that give healthcare professionals new ways to dive into content with AI chatbots and explore real-world cases. It’s not just about better learning – it’s about smarter, faster learning. We’re committed to staying ahead in medical education. Nobody understands medical education like Medscape, and we’re not just keeping up with tech – we’re leading the charge. We’re using our expertise to make AI work for our learners. This AI pilot is just the start. We’re focused on giving healthcare professionals the best learning experience out there, because better education means better patient care.” Dr Sushant Dahiya, Executive Director, Medscape Education

For more information on hematology and oncology education at Medscape, please contact Christine Carey. For more information on patient-integration, please contact Victoria Harvey-Jones,  or for how we are harnessing AI to power learning with impact contact Dr Sushant Dahiya.

 

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Medscape Oncology to Make a Significant Impact at ASCO 2024

ASCO is one of the biggest conferences of the year for Medscape Oncology, and the team is ready to make an impact in Chicago. They’ll be manning booth #26030, where...

Medscape Oncology Launches Inaugural Medscape Fellows Program at ASCO 2024

Medscape Oncology is excited to announce the launch of the first-ever Medscape Fellows Program at the 2024 ASCO meeting in Chicago, Illinois. This groundbreaking program aims to nurture young oncology...

Navigating Food Allergy Management: Trends, Treatments, and Decision-Making

Are you having trouble navigating the management of food allergies? Join our faculty experts for a live conversation on social media to learn about the evolving complexities in food allergy...

The Power of Patient Insights to Improve Cancer Care

Two global patient advocacy groups—The Lymphoma Coalition and Lung Cancer Europe— are compiling data from their communities on the real-world experience of living with cancer. What the data reveals sometimes...

Medscape Education Continues Its Patient-Centric Mission at EHA 2024

Anticipation is building at Medscape Education as the team prepares for the EHA 2024 Congress. Medscape Education is excited to announce a significant presence during the congress including a Medscape...

Getting in-sync with Public Health at SYNC 2024

Medscape Education is bringing its public health efforts to Washington, DC for the SYNC conference on HIV, HCV, STIs, Harm Reduction, and LGBTQ health. During the conference, Lindsey will present...

Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care

Ahead of the 61st European Renal Association (ERA) Congress, Medscape Education and KDIGO (Kidney Disease: Improving Global Outcomes) announce an educational collaboration through a series of webinars to improve anemia-related...

Medscape Brings Impact and Data to ESPGHAN

The ESPGHAN Congress in Milan was full of impact as Medscape Education Global presented 5 scientific posters examining the outcomes of their education. The posters detailed the impact Medscape Education...

Empowering Nurses Through Education

Nurse education is powerful and makes an impact.

Pioneering Paths: Women Leadership in Rare Disease

Rare diseases are often thought of as affecting one in 100,000 or one in 1,000,000 people, and that is true for some conditions. But there are many rare diseases that...